台股 » 個股 » 生華科 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

生華科

(6492)
可現股當沖
  • 股價
    42.40
  • 漲跌
    ▼0.20
  • 漲幅
    -0.47%
  • 成交量
    142
  • 產業
    上櫃 生技醫療類股
  • 154人加入追蹤

    立即追蹤

  • 本地時間:14:30(已收盤)

     
生華科 (6492)籌碼相關-群益金鼎-新莊 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw04/0404/2005/0405/1805/3006/0806/2212/2001/2003/1407/0607/2208/0208/1608/3009/1409/3010/1210/2611/0811/2212/0601/0402/1002/2003/04404244464850May '24Jul '24Sep '24Nov '24Jan '25Mar '2560d90dAll

群益金鼎-新莊 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/03/1300.00143.9042.60-1148-0.67%
2025/03/12144.1000.0044.1011470.68%
2025/03/03046.00145.3044.60-1153-0.65%
2025/02/2500.00145.5045.60-1153-0.65%
2025/02/240.245.9000.0045.850.21560.13%
2025/02/21245.8800.0045.4021531.30%
2025/02/20046.1000.0045.2501480.00%
2025/02/180.244.3000.0044.250.21580.12%
2025/02/170.244.5000.0044.750.21620.11%
2025/02/13144.0000.0044.0011660.60%
2025/02/1200.00143.6044.05-1168-0.59%
2025/02/11143.7000.0043.7511760.57%
2025/02/0700.00144.1044.20-1186-0.54%
2025/02/060.343.5000.0044.250.31900.13%
2025/01/21041.9000.0042.7003440.00%
2025/01/17142.4000.0042.0013790.26%
2025/01/1600.00142.3042.35-1378-0.26%
2025/01/1300.00142.3042.35-1384-0.26%
2025/01/09144.8000.0043.9513860.26%
2025/01/06043.4000.0043.4003950.01%
2024/12/310.143.5000.0043.500.14100.02%
2024/12/26144.10144.2044.0504290.00%
2024/12/1600.00141.8042.35-1585-0.17%
2024/12/090.144.6500.0043.800.16000.02%
2024/12/060.144.2000.0044.150.16110.02%
2024/12/04146.00145.6045.3506200.00%
2024/11/21246.0500.0045.6526710.30%
2024/11/19144.9500.0045.4516880.15%
2024/11/150.146.82146.3046.25-0.9696-0.13%
2024/10/28255.50255.8552.6007560.00%
2024/10/0900.00249.2049.15-21,059-0.19%
2024/09/30255.6000.0054.4021,0460.19%
2024/09/2600.000.152.4051.90-0.11,023-0.01%
2024/09/2400.000.154.1053.40-0.11,019-0.01%
2024/09/2300.000.154.7054.60-0.11,019-0.01%
2024/09/20155.09154.5055.0001,0230.00%
2024/09/19156.301.155.9553.20-0.1995-0.01%
2024/09/13148.5000.0047.8019670.10%
2024/09/1200.00147.0047.30-1979-0.10%
2024/09/040.248.7000.0047.850.21,0170.02%
2024/09/03151.50151.2051.4001,0070.00%
2024/09/0200.00150.2050.70-11,003-0.10%
2024/08/29151.2000.0050.0019930.10%
2024/08/28149.8000.0050.3019810.10%
2024/08/2700.00149.4549.00-1973-0.10%
2024/08/23149.4000.0049.3519660.10%
2024/08/1600.00249.6550.10-2928-0.22%
2024/08/141.247.3300.0047.051.29010.13%
2024/08/130.147.3000.0047.100.18940.01%
2024/08/0900.00148.2548.15-1879-0.11%
2024/08/07152.2000.0050.7018560.12%
2024/08/061048.661049.2349.0008410.00%
2024/08/05249.00147.7047.7018180.12%
2024/08/02254.80255.0053.0008090.00%
2024/08/01455.48155.9055.4038040.37%
2024/07/31255.85255.9556.5007990.00%
2024/07/2900.00157.5056.90-1788-0.13%
2024/07/26453.73454.0554.5007760.00%
2024/07/19158.10161.5058.1007350.00%
2024/07/18160.40660.2762.20-5658-0.76%
2024/07/171.157.50259.3558.90-0.9543-0.17%
2024/07/1600.00556.8657.20-5427-1.17%
2024/07/11243.1500.0043.0023180.63%
2024/07/10143.4500.0043.3513190.31%
2024/07/091.243.3600.0043.401.23190.37%
2024/07/040.244.9000.0044.850.23100.05%
2024/07/0200.00145.7045.50-1307-0.33%
2024/06/28047.0500.0047.1002990.01%
2024/06/21147.5000.0045.2012580.39%
2024/06/200.247.6000.0047.600.22500.08%
2024/06/180.444.0000.0044.000.42130.19%
2024/06/1700.00343.8245.35-3187-1.60%
2024/06/1100.00143.0042.60-1151-0.66%
2024/06/04141.7000.0041.8011530.65%
2024/05/2900.00142.0041.90-1163-0.61%
2024/05/28142.0000.0042.3011640.61%
2024/05/2700.00241.2041.35-2164-1.21%
2024/05/2400.00141.4541.45-1170-0.59%
2024/05/2300.00142.5042.10-1172-0.58%
2024/05/22143.2000.0043.2511740.57%
2024/05/20142.1000.0041.9511740.57%
2024/05/17242.48242.3042.4501770.00%
2024/05/16442.6800.0041.7041772.26%
2024/05/0600.00241.7541.75-2181-1.10%
2024/05/03142.00141.7041.7501820.00%
2024/05/02241.80241.6541.6501820.00%
2024/04/29241.0300.0041.3021831.09%
2024/04/24141.0000.0041.1011830.54%
2024/03/29144.30144.2044.1001980.00%
2024/03/27143.4500.0043.5012000.50%
2024/03/2600.00343.6043.05-3202-1.48%
2024/03/21343.5800.0042.7032001.49%
生華科新藥再獲孤兒藥資格 上市可獲7年市場獨賣保護期Anue鉅亨-2024/10/25
上櫃「肥貓」董監現形 台嘉碩、大宇資、穩懋、生華科為前四肥Anue鉅亨-2024/04/15
生華科治療新冠、流感等泛病毒感染新藥 將啟動二期臨床Anue鉅亨-2023/11/21
生華科 相關文章
生華科 相關影音